Lovenox Marketing Documents Subpoenaed By Chicago U.S. Attorney
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi-Aventis is responding to a subpoena issued by the Chicago U.S. Attorney regarding "sales and marketing practices" for the low molecular weight heparin product Lovenox, the company disclosed Oct. 21